# D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia

> **NCT04584580** · PHASE4 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 50 (estimated)

## Conditions studied

- Coronavirus Disease (COVID)19

## Interventions

- **DRUG:** low-molecular-weight heparin

## Key facts

- **NCT ID:** NCT04584580
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-01
- **Primary completion:** 2020-10-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2020-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04584580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04584580, "D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04584580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*